In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Kalimin Drug Master File in Korea (Kalimin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Kalimin. The MFDS reviews the Kalimin KDMF as part of the drug registration process and uses the information provided in the Kalimin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Kalimin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Kalimin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Kalimin suppliers with KDMF on PharmaCompass.